Latest Issue
PharmTech
Latest Issue
PharmTech Europe
| Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe | |||
|
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts. |
|||
|
Industry Briefs: December 31, 2012
Company News Almac Discovery has selected ALM301, a subtype selective Akt1 and Akt2 inhibitor, for its allosteric Akt inhibitor program. Read More Radius Health and 3M Drug Delivery Systems have formed an exclusive agreement for the development and commercialization for the transdermal delivery of BA058, a synthetic proprietary peptide analog of human parathyroid hormone-related protein for treating osteoporosis. Read More WuXi PharmaTech and PRA have formed a joint venture to offer clinical-research services for the Chinese market. Read More
|
|
|||||||||||||||